NCT03291808

Brief Summary

This is to pilot test a weight loss intervention in obese patients with poorly controlled asthma. Obesity is a risk factor for the development of asthma (approximately 250,000 cases per year of asthma in the U.S. are related to obesity). Investigators' ultimate purpose is to test the hypothesis that weight loss through an intensive life style intervention will improve asthma control. But investigators first need to establish whether the weight loss intervention is effective in patients with asthma. Objectives

  1. 1.The primary objective of this study is to determine the effectiveness of an internet-based weight loss intervention in producing weight loss in obese patients with poorly controlled asthma.
  2. 2.The ultimate purpose is to implement a multi-center weight loss intervention trial for obese patients with poorly controlled asthma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable asthma

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable asthma

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 25, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

November 15, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2020

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

September 21, 2022

Completed
Last Updated

September 21, 2022

Status Verified

August 1, 2022

Enrollment Period

2.5 years

First QC Date

September 21, 2017

Results QC Date

May 12, 2022

Last Update Submit

August 26, 2022

Conditions

Keywords

ObesityAsthmaWeight loss

Outcome Measures

Primary Outcomes (1)

  • Weight Loss

    The primary outcome of interest will be the percent of participants achieving a 5% weight loss, which is the amount of weight loss that prior studies suggest is required to improve asthma control.

    6 months

Study Arms (1)

Weight loss intervention

EXPERIMENTAL

Such designs are widely used in efficiently informing decisions to proceed to Phase III clinical trials. This trial design is appropriate when the effect of the placebo arm can reasonably be estimated (weight loss is likely to be close to 0), and the toxicity of the treatment is minimal (no toxicity is anticipated related to weight loss).18 Therefore, this will be a single arm 6-month study of 40 participants (20 at each site). All participants will be assigned to the weight loss intervention.

Behavioral: Weight loss intervention

Interventions

This 6-month intervention will include restricted calorie intake and increased physical activity. Key behavioral strategies to facilitate changes in dietary habits and activity patterns will be introduced, promoted and reinforced throughout the program. Weekly "group meetings" in a synchronous chat (i.e., in real time) led by a facilitator will be the venue for the group process. Extensive web-based resources to support behavior changes will be offered. Group chat sessions will meet online weekly for 6 months.

Weight loss intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physician diagnosis of asthma on regular prescribed controller therapy for at least 3 months
  • Age: ≥18 years of age
  • Obese: BMI \> 30 kg/m2
  • Poorly controlled asthma
  • Asthma Control Test Score \< 19,19,20 or
  • Use of rescue inhaler, on average, \> 2 uses/week for preceding month, or
  • Nocturnal asthma awakening, on average,1 or more times / week in preceding month, or
  • Emergency Department (ED)/hospital visit or prednisone course for asthma in past six months
  • Ability and willingness to provide informed consent
  • Ability to access internet weight loss program for trial period
  • Completion of asthma diary cards and weight loss diary cards for same 3 consecutive days at visit 2

You may not qualify if:

  • Prior history of bariatric surgery
  • Any condition that puts the participant at risk from participation in a weight loss study or a condition that precludes participation in regular exercise as judged by the site physician.
  • Pregnancy (by patient self-report)
  • Participation in another weight loss intervention within the last month
  • Weight loss of ≥ 10 pounds in the last 6 months by self-report

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Arizona

Tucson, Arizona, 85724, United States

Location

University of Vermont

Burlington, Vermont, 05401, United States

Location

Related Publications (1)

  • Johnson O, Gerald LB, Harvey J, Roy G, Hazucha H, Large C, Burke A, McCormack M, Wise RA, Holbrook JT, Dixon AE. An Online Weight Loss Intervention for People With Obesity and Poorly Controlled Asthma. J Allergy Clin Immunol Pract. 2022 Jun;10(6):1577-1586.e3. doi: 10.1016/j.jaip.2022.02.040. Epub 2022 Mar 15.

Related Links

MeSH Terms

Conditions

AsthmaObesityWeight Loss

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Results Point of Contact

Title
Gem Roy
Organization
Johns Hopkins University

Study Officials

  • Anne Dixon, MD

    University of Vermont

    PRINCIPAL INVESTIGATOR
  • Robert Wise, MD

    Johns Hopkins School of Medicine

    PRINCIPAL INVESTIGATOR
  • Janet Holbrook, PhD

    Johns Hopkins Bloomberg School of Public Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2017

First Posted

September 25, 2017

Study Start

November 15, 2017

Primary Completion

May 31, 2020

Study Completion

May 31, 2020

Last Updated

September 21, 2022

Results First Posted

September 21, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations